Wednesday, March 31, 2021 11:29:13 AM
$RLFTF View of Role of Aviptadil in COVID-19 | BMH Medical Journal - ISSN 2348–392X
https://www.babymhospital.org/BMH_MJ/index.ph...ew/300/631
" Conclusion Synthetic VIP, Aviptadil is found to reduce viral replication in lung tissues, release of inflammatory cytokines and alveolar epithelial cell apoptosis in patients with corona virus infection. On-going clinical trials will be expected to through more light into the role of Aviptadil in COVID-19. "
https://www.babymhospital.org/BMH_MJ/index.ph...ew/300/631
" Conclusion Synthetic VIP, Aviptadil is found to reduce viral replication in lung tissues, release of inflammatory cytokines and alveolar epithelial cell apoptosis in patients with corona virus infection. On-going clinical trials will be expected to through more light into the role of Aviptadil in COVID-19. "
~ Money Making Money ~
Recent RLFTF News
- MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank • ACCESS Newswire • 03/19/2026 06:35:00 AM
- MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics • ACCESS Newswire • 12/23/2025 06:20:00 AM
- Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics • ACCESS Newswire • 12/15/2025 06:20:00 AM
- Relief Therapeutics Shareholders Approve Business Combination with NeuroX • ACCESS Newswire • 11/14/2025 05:40:00 PM
- Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032 • ACCESS Newswire • 10/29/2025 06:20:00 AM
